Inhibition of many kinases targeted by 2062, such as PIKfyve, VPS34, JAKs and Tyk2, would not benefit a host with TB by impairing endosomal trafficking, phagolysosomal fusion and IFNγ signaling. This evidence concerns the gene IFNG and tuberculosis.